Skip to content

TMS in Borderline Personality Disorder Patients

Repetitive Transcranial Magnetic Stimulation in Borderline Personality Disorder Patients. Effects in Clinical Measurements, Inhibition, Cognitive Flexibility, and Social Cognition Process

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02273674
Enrollment
40
Registered
2014-10-24
Start date
2014-01-31
Completion date
2016-02-29
Last updated
2016-02-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Borderline Personality Disorder

Keywords

Borderline Personality Disorder, Transcranial Magnetic Stimulation, Repetitive

Brief summary

The purpose of this study is to determine the potential effects of repetitive transcranial magnetic stimulation in the improvement of neuropsychological deficits and symptomatology in borderline personality disorder patients. Specially in cognitive flexibility, inhibition control and social cognition.

Detailed description

This is a randomized, parallel group clinical trial to evaluate the efficacy of two protocols of repetitive Transcranial Magnetic Stimulation (rTMS), the application will be over dorsolateral prefrontal cortex (DLPFC) right and left, in patients with borderline personality disorder. 40 ambulatory patients with a borderline personality disorder diagnosis from the National Institute of Psychiatry in México will be included. All Patients will be randomly assigned and will complete a total of 23 sessions rTMS, in any of two groups: 5 Hz Group.- This group will receive rTMS sessions, 5 per week during three weeks (acute treatment phase), and after that, one session a week for the next eight weeks (follow up). The rTMS will be applied over the left DLPFC at 5 Hz, 1500 pulses per session in 100% of Motor threshold 1 Hz Group.- This group will receive rTMS sessions, 5 per week during three weeks (acute treatment phase), and after that, one session a week for the next eight weeks (follow up). The rTMS will be applied over the right DLPFC at 1 Hz, 900 pulses per session in 100% of Motor threshold All sessions will be applied with a Dantec transcranial magnetic stimulator. The affective, borderline and anxiety symptoms will be evaluated at baseline, and every 5 TMS sessions during the acute treatment phase, and once at the end of the 8-weeks follow up. In same form for neuropsychological evaluations . Categorical variables will be described by percentages and frequencies. Continuous variables will be described by means and standard deviations. Treatment groups will be compared using Student's T test. Cognitive, anxiety, borderline and affective symptom scale scores between treatment groups will be compared using repeated measures ANOVA

Interventions

DEVICELeft rTMS 5 Hz

The subjects will receive transcranial magnetic stimulation (5 Hz of frequency over left dorsolateral prefrontal cortex . Once a day on monday to friday. Until receive 15 sessions. After this the subjects, will be received 8 more sessions of TMS, one session at week for next eight weeks

DEVICERight r TMS 1 Hz

The subjects will receive transcranial magnetic stimulation (1 Hz of frequency over right dorsolateral prefrontal cortex . Once a day on monday to friday. Until receive 15 sessions. After this the subjects, will be received 8 more sessions of TMS, one session at week for next eight weeks

Sponsors

Universidad Nacional Autonoma de Mexico
CollaboratorOTHER
Instituto Nacional de Psiquiatría Dr. Ramón de la Fuente
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to 45 Years
Healthy volunteers
No

Inclusion criteria

* Diagnosis of borderline personality disorder according to diagnostic and statistical manual of mental disorders IV text revision * Treatment with selective inhibitors of serotonin reuptake * Mass corporal index more than 19

Exclusion criteria

* Suicide risk or suicide attempt recent or actual * History of epilepsy or seizures * History of cranial trauma with loss awareness * Intracranial or intraocular ferromagnetic devices, including skull prosthesis. * Pregnant womens. * Neurosurgery, cardiac pacemaker, lefthander * Patients with psychotic symptoms, bipolar disorder or substance addiction.

Design outcomes

Primary

MeasureTime frameDescription
Change from Baseline in BORDERLINE EVALUATION OF SEVERITY OVER TIME (BEST)Inclusion, after 15 days of treatment and at 8 weeks follow upThe Borderline Evaluation of Severity Over Time (BEST) was developed to rate the thoughts, emotions, and behaviors typical of borderline personality disorder.

Secondary

MeasureTime frameDescription
Change from Baseline in Barratt impulsiveness scaleIInclusion, after 15 days of treatment and at 8 weeks follow upThe Barratt Impulsiveness Scale is a questionnaire designed to assess the personality/behavioral construct of impulsiveness.
Change from Baseline in Hamilton Depression rating scaleInclusion, after 15 days of treatment and at 8 weeks follow upThe Hamilton depression rating scale is a is a multiple item questionnaire used to provide an indication of depression, and as a guide to evaluate recovery
Change from Baseline in Wisconsin card sorting test (WCST)Inclusion, after 15 days of treatment and at 8 weeks follow upWCST is used primarily to assess perseveration and abstract thinking, the WCST is also considered a measure of executive function because of its reported sensitivity to frontal lobe dysfunction.
Change from Baseline in Stop Signal Task (SST)Inclusion, after 15 days of treatment and at 8 weeks follow upSST measuring response inhibition (impulse control). The subject must respond to an arrow stimulus, by touching either of two choices depending on the direction in which the arrow points. If an audio tone is present, the subject must inhibit that response.
Change from Baseline in Reading the Mind in the Eyes TestInclusion, after 15 days of treatment and at 8 weeks follow upThe 'Reading the Mind in the Eyes' (Eyes) test is an advanced test of theory of mind. It is widely used to assess individual differences in social cognition and emotion recognition across different groups and cultures.

Countries

Mexico

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 26, 2026